Revi, Neeraja and Rengan, Aravind Kumar
(2020)
Eugenol-Encapsulated Nanocarriers for Microglial Polarisation: a Promising Therapeutic Application for Neuroprotection.
BioNanoScience, 10 (4).
pp. 1010-1017.
ISSN 2191-1630
Full text not available from this repository.
(
Request a copy)
Abstract
Neuroinflammation is an important hallmark of central nervous system (CNS) disorders like Alzheimer’s and Parkinson’s disease. It is caused by the prolonged activation of microglia, resident immune cells of the brain. Microglia cells are considered to be the first line of defence in our central nervous system. Depending on the local environment, these brain macrophage cells can adopt different phenotypic states to carry out downstream functions. They undergo polarisation to change into the pro-inflammatory or anti-inflammatory phenotype, causing either neuroinflammation or neuroprotection. Novel therapeutic approaches which aim to control microglial polarisation properties are thus considered. This study investigates the possibility of microglial polarisation properties of eugenol, a polyphenol, after encapsulating it in a lipid nanocarrier system. As part of the current study, eugenol-loaded lipid nanocarriers of size less than 200 nm was synthesised, and their cytotoxicity on neuronal and non-neuronal cell lines was tested. In lipopolysaccharide (LPS)-induced BV2 microglia cells, the two test concentrations of eugenol-loaded nanocarriers resulted in reduced nitrite concentration, indicating a switch from the pro-inflammatory to an anti-inflammatory state. [Figure not available: see fulltext.] © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
[error in script]
IITH Creators: |
IITH Creators | ORCiD |
---|
Rengan, Aravind Kumar | https://orcid.org/0000-0003-3994-6760 |
|
Item Type: |
Article
|
Additional Information: |
The authors would like to express their gratitude to the Ministry of Human Resources and Development (MHRD), Dept. of Science & Technology (DST) and Dept. of Biotechnology (DBT), Govt. of India, for funding. The first author is funded by Ministry of Human Resources and Development (MHRD), India, for her graduate thesis research of which this study is a part of. Consumables for the project were purchased using monetary support from the following funding programmes: DST-Inspire (DST/INSPIRE/04/2015/000377), DBT-NNT (BT/NNT/28/1386/2017). Acknowledgements |
Uncontrolled Keywords: |
Eugenol; Microglia; Neurodegenerative disorders; Neuroinflammation; Polarisation |
Subjects: |
Biomedical Engineering |
Divisions: |
Department of Biomedical Engineering |
Depositing User: |
. LibTrainee 2021
|
Date Deposited: |
03 Nov 2022 09:46 |
Last Modified: |
03 Nov 2022 09:46 |
URI: |
http://raiithold.iith.ac.in/id/eprint/11139 |
Publisher URL: |
http://doi.org/10.1007/s12668-020-00789-z |
OA policy: |
https://v2.sherpa.ac.uk/id/publication/28054 |
Related URLs: |
|
Actions (login required)
|
View Item |